Regeneron Pharmaceuticals, Inc.
METHODS FOR TREATING ASTHMA IN PEDIATRIC SUBJECTS BY ADMINISTERING AN IL-4R ANTAGONIST
Last updated:
Abstract:
Methods for treating or preventing asthma in a pediatric subject are provided. Methods comprising administering to a pediatric subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.
Status:
Application
Type:
Utility
Filling date:
4 Oct 2021
Issue date:
2 Jun 2022